ArticleFrontiers in medicine2026
Two-year outcomes of trabeculo-canalectomy for glaucoma secondary to iridocorneal endothelial syndrome: a retrospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The study aimed to evaluate the 2-year outcomes of a new surgical procedure for treating Chinese patients with glaucoma secondary to iridocorneal endothelial syndrome (GS-ICE). Methods: This was a retrospective study involving 26 GS-ICE patients (26 eyes) surgically treated with trabeculo-canalectomy in the First Affiliated Hospital with Nanjing Medical University from January 2015 to June 2024, and postoperatively followed up for 2 years. An intraocular pressure (IOP) of lower than 21 mmHg (1 mmHg = 0.133 kPa) with (conditional success) or without anti-glaucoma medication (complete success) was set as the cut-off value of surgical success. Main outcomes of trabeculo-canalectomy for GS-ICE included IOP, number of medications, surgical success, and complications. Results: A total of 26 GS-ICE patients (26 eyes) with an average age of 48.58 ± 9.61 (27-67) years and a median number of 2 (0-4) anti-glaucoma medication regimens were retrospectively included. Compared to the preoperative value (31.10 ± 11.00 mmHg), the postoperative mean IOP was significantly lower, reaching 13.27 ± 2.68, 15.00 ± 3.77, 15.04 ± 2.81, 16.27 ± 3.03, 16.96 ± 3.12, and 16.89 ± 3.18 mmHg at 1 week, 1 month, 3 months, 6 months, 1 year, and 2 years, respectively ( Conclusion: Trabeculo-canalectomy brings favorable two-year outcomes among GS-ICE patients, including an effective IOP control, a reduction of anti-glaucoma medications, and a low risk of postoperative complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.